Torrent Pharmaceuticals Ltd
NSE: TORNTPHARM BSE: 500420
₹4078
(0.02%)
Sat, 14 Feb 2026, 07:11 am
Market Cap1381.34B
PE Ratio64.49
Dividend0.78
Health Technology
Pharmaceuticals: Major
24.5KTorrent Pharmaceuticals Financials
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 9.34B | 12.62B | 13.12B | 15.85B | 18.28B | 21.22B | 25.89B | 30.45B | 40.23B | 45.68B | 65.44B | 57.32B | 59.18B | 75.89B | 78.53B | 79.52B | 84.81B | 95.37B | 106.05B | 113.58B |
| Gross profit | 1.34B | 5.01B | 2.70B | 7.08B | 8.00B | 8.70B | 10.38B | 12.07B | 18.27B | 19.65B | 37.95B | 25.64B | 26.07B | 28.86B | 32.10B | 32.47B | 33.65B | 39.49B | 46.76B | 51.03B |
| Operating expenses (excl. COGS) | -829.81M | -4.09B | -1.42B | -4.93B | -5.21B | -6.27B | -6.68B | -7.38B | -9.71B | -11.64B | -12.68B | -15.21B | -16.88B | -15.44B | -17.05B | -14.16B | -16.08B | -18.36B | -21.42B | -22.53B |
| Selling/general/admin expenses, total | — | -4.10B | — | -4.28B | -5.19B | -5.52B | -6.94B | -7.30B | -10.16B | -12.00B | -13.91B | -15.21B | -16.88B | -15.44B | -17.05B | -14.16B | -15.62B | -18.36B | -21.42B | -22.53B |
| Research & development | -564.24M | -770.15M | -971.57M | -1.12B | -1.20B | -1.39B | -1.17B | -111.14M | -1.31B | -1.54B | -2.09B | -3.59B | -3.44B | -5.38B | -4.94B | -4.87B | -5.16B | -5.16B | -5.27B | -5.81B |
| Selling/general/admin expenses, other | — | -3.32B | — | -3.16B | -3.98B | -4.13B | -5.77B | -7.19B | -8.85B | -10.46B | -11.82B | -11.62B | -13.43B | -10.06B | -12.11B | -9.29B | -10.46B | -13.20B | -16.15B | -16.72B |
| Other operating expenses, total | -829.81M | 8.81M | -1.42B | -651.23M | -20.41M | -751.26M | 260.41M | -81.60M | 458.40M | 355.20M | 1.22B | 0 | 0 | 0 | 0 | 0 | -456.80M | 0 | 0 | 0 |
| Operating income | 505.40M | 919.16M | 1.28B | 2.15B | 2.80B | 2.43B | 3.40B | 4.69B | 8.04B | 7.61B | 24.05B | 10.43B | 9.20B | 13.42B | 15.06B | 18.31B | 17.57B | 21.13B | 25.34B | 28.50B |
| Non-operating income, total | 245.80M | 147.88M | 188.05M | -267.04M | 676.52M | 995.49M | 187.06M | 1.13B | 399.00M | 1.78B | -612.10M | 465.80M | 189.80M | -7.81B | -3.19B | -3.05B | -5.32B | -2.66B | -1.81B | -1.77B |
| Interest expense, net of interest capitalized | -99.54M | -236.44M | -228.56M | -392.96M | -291.02M | -386.50M | -394.54M | -338.00M | -586.30M | -1.75B | -1.84B | -2.06B | -3.08B | -5.04B | -4.51B | -3.53B | -2.55B | -3.33B | -3.54B | -2.52B |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 553.00M | 272.70M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40.10M |
| Non-operating income, excl. interest expenses | 345.34M | 384.32M | 416.61M | 242.76M | 967.54M | 1.38B | 1.24B | 1.91B | 848.80M | 3.54B | 2.98B | 2.66B | 3.40B | -497.50M | 1.35B | 487.10M | 1.62B | 716.30M | 1.85B | 996.80M |
| Non-operating interest income | 38.15M | 74.42M | 32.13M | 202.84M | 125.93M | 265.94M | 328.30M | 338.10M | 274.20M | 145.80M | 60.00M | 48.50M | 66.60M | 164.10M | 79.60M | 50.70M | 71.50M | 147.80M | 114.80M | 201.90M |
| Miscellaneous non-operating expense | 307.19M | 309.90M | 384.47M | 39.92M | 841.61M | 1.12B | 906.95M | 1.57B | 574.60M | 3.39B | 2.92B | 2.61B | 3.29B | -733.30M | 1.27B | 436.40M | 1.55B | 555.00M | 1.74B | 789.90M |
| Unusual income/expense | — | — | — | -116.83M | — | — | -653.64M | -445.50M | 136.50M | — | -1.75B | -141.60M | -124.20M | -2.27B | -39.90M | -4.00M | -4.39B | -44.20M | -128.40M | -241.80M |
| Pretax income | 751.20M | 1.07B | 1.47B | 1.89B | 3.47B | 3.43B | 3.59B | 5.82B | 8.44B | 9.40B | 23.43B | 10.88B | 9.31B | 5.62B | 11.87B | 15.26B | 12.26B | 18.47B | 23.52B | 26.73B |
| Taxes | -189.09M | -131.91M | -118.84M | -44.01M | -1.16B | -725.09M | -723.15M | -1.47B | -1.80B | -1.89B | -6.10B | -1.55B | -2.53B | -1.25B | -1.62B | -2.74B | -4.49B | -6.02B | -6.96B | -7.62B |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 | 0 | 41.00K | -22.61M | -21.50M | -300.00K | -300.00K | -300.00K | -300.00K | -300.00K | -300.00K | 0 | 0 | 0 | 0 | 0 | 0 |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 562.11M | 935.13M | 1.35B | 1.84B | 2.31B | 2.70B | 2.84B | 4.33B | 6.64B | 7.51B | 17.33B | 9.34B | 6.78B | 4.36B | 10.25B | 12.52B | 7.77B | 12.45B | 16.56B | 19.11B |
| Net income | 562.11M | 935.13M | 1.35B | 1.84B | 2.31B | 2.70B | 2.84B | 4.33B | 6.64B | 7.51B | 17.33B | 9.34B | 6.78B | 4.36B | 10.25B | 12.52B | 7.77B | 12.45B | 16.56B | 19.11B |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 562.11M | 935.13M | 1.35B | 1.84B | 2.31B | 2.70B | 2.84B | 4.33B | 6.64B | 7.51B | 17.33B | 9.34B | 6.78B | 4.36B | 10.25B | 12.52B | 7.77B | 12.45B | 16.56B | 19.11B |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | 760.58M | 1.25B | 1.67B | 2.58B | 3.46B | 3.06B | 4.52B | 5.51B | 9.43B | 9.91B | 27.65B | 13.37B | 13.28B | 19.57B | 21.57B | 24.88B | 24.19B | 28.15B | 33.29B | 36.45B |
| EBIT | 505.40M | 919.16M | 1.28B | 2.15B | 2.80B | 2.43B | 3.70B | 4.69B | 8.56B | 8.01B | 25.27B | 10.43B | 9.20B | 13.42B | 15.06B | 18.31B | 17.57B | 21.13B | 25.34B | 28.50B |
| Total operating expenses | -8.83B | -11.71B | -11.84B | -13.69B | -15.48B | -18.79B | -22.50B | -25.76B | -32.19B | -38.06B | -40.17B | -46.89B | -49.99B | -62.47B | -63.47B | -61.21B | -67.24B | -74.24B | -80.72B | -85.09B |
| Prepaid expenses | 80.11M | 88.66M | 91.71M | 46.10M | 54.25M | 115.17M | — | — | — | — | 218.20M | 237.20M | 370.10M | 404.00M | 526.40M | 548.00M | 514.60M | 666.90M | 589.50M | 631.10M |
| Deferred income, current | — | — | — | — | — | — | — | — | — | — | — | 98.10M | 99.90M | 96.20M | 116.60M | 87.30M | 101.30M | 13.30M | 45.00M | 19.40M |
| Capital and operating lease obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 222.00M | 368.20M | 368.20M | 529.30M | 644.60M | 1.46B |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | 575.72M | 694.82M | 761.84M | 683.31M | 621.91M | 617.05M | 770.87M | 569.10M | 474.80M | 1.89B | 2.89B | 4.19B | 6.13B | 8.27B | — | — | 1.94B | 4.02B | 6.56B | 8.29B |
| Deferred income, non-current | 0 | 0 | 0 | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — | — | — | — | — |
| Minority interest | 0 | 0 | 0 | 0 | 0 | 16.01M | 35.02M | 3.70M | 4.00M | 4.30M | 4.60M | 4.90M | 5.20M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in accrued expenses | 0 | — | 0 | 0 | 0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | -193.15M | -531.69M | -1.08M | -331.86M | -410.15M | -591.16M | -1.37B | -834.40M | -2.67B | -2.00B | -8.40B | -2.04B | -2.65B | -3.10B | -7.18B | -3.38B | -6.77B | -8.63B | -10.15B | -10.83B |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800